SPRED2 can regulate the proliferation and apoptosis of chronic myelogenous leukemia and hepatoma cells and inhibit the growth of tumors by inhibiting the RAS/MAPK pathway25. The gene discussed is SPRED2; the disease is hepatocellular carcinoma.